These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27002480)

  • 1. Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.
    Shin J; Kim G; Lee JW; Lee JE; Kim YS; Yu JH; Lee ST; Ahn SH; Kim H; Lee C
    Cancer Sci; 2016 Jun; 107(6):828-35. PubMed ID: 27002480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
    Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
    BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
    Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
    J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mouse gene encoding the GM2 activator protein (Gm2a): cDNA sequence, expression, and chromosome mapping.
    Yamanaka S; Johnson ON; Lyu MS; Kozak CA; Proia RL
    Genomics; 1994 Dec; 24(3):601-4. PubMed ID: 7713516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers.
    Risha Y; Minic Z; Ghobadloo SM; Berezovski MV
    Sci Rep; 2020 Aug; 10(1):13572. PubMed ID: 32782317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling.
    de Wit M; Kant H; Piersma SR; Pham TV; Mongera S; van Berkel MP; Boven E; Pontén F; Meijer GA; Jimenez CR; Fijneman RJ
    J Proteomics; 2014 Mar; 99():26-39. PubMed ID: 24418523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an alternatively spliced GM2 activator protein, GM2A protein. An activator protein which stimulates the enzymatic hydrolysis of N-acetylneuraminic acid, but not N-acetylgalactosamine, from GM2.
    Wu YY; Sonnino S; Li YT; Li SC
    J Biol Chem; 1996 May; 271(18):10611-5. PubMed ID: 8631864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach.
    Wang LN; Tong SW; Hu HD; Ye F; Li SL; Ren H; Zhang DZ; Xiang R; Yang YX
    J Cell Biochem; 2012 Dec; 113(12):3762-72. PubMed ID: 22807371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas.
    Wu CC; Hsu CW; Chen CD; Yu CJ; Chang KP; Tai DI; Liu HP; Su WH; Chang YS; Yu JS
    Mol Cell Proteomics; 2010 Jun; 9(6):1100-17. PubMed ID: 20124221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
    Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
    J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.
    Whelan SA; He J; Lu M; Souda P; Saxton RE; Faull KF; Whitelegge JP; Chang HR
    J Proteome Res; 2012 Oct; 11(10):5034-45. PubMed ID: 22934887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
    PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer.
    Xu X; Qiao M; Zhang Y; Jiang Y; Wei P; Yao J; Gu B; Wang Y; Lu J; Wang Z; Tang Z; Sun Y; Wu W; Shi Q
    Proteomics; 2010 Apr; 10(7):1374-90. PubMed ID: 20198662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unconventional secretion is a major contributor of cancer cell line secretomes.
    Villarreal L; Méndez O; Salvans C; Gregori J; Baselga J; Villanueva J
    Mol Cell Proteomics; 2013 May; 12(5):1046-60. PubMed ID: 23268930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.
    Luo X; Liu Y; Wang R; Hu H; Zeng R; Chen H
    J Proteomics; 2011 Apr; 74(4):528-38. PubMed ID: 21262398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of protein patterns of human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines.
    Flodrova D; Toporova L; Macejova D; Lastovickova M; Brtko J; Bobalova J
    Gen Physiol Biophys; 2016 Jul; 35(3):387-92. PubMed ID: 27174898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.